In Norway, the uptake of infliximab biosimilars as of 4th quarter 2018 was 98 percent, and thus the highest among developed countries (OECD). That means that 98 percent of all used units of that drug were biosimilars.
Uptake of infliximab biosimilars in select countries as of 2018, by share of units
Characteristic
Share of units
Norway
98%
Poland
96%
United Kingdom
92%
Austria
89%
Italy
79%
Sweden
78%
Slovenia
64%
Portugal
63%
France
60%
Czechia
59%
Spain
56%
Germany
53%
Ireland
40%
Created with Highcharts 7.2.2Share of units98%98%96%96%92%92%89%89%79%79%78%78%64%64%63%63%60%60%59%59%56%56%53%53%40%40%37%37%36%36%30%30%23%23%22%22%17%17%17%17%16%16%9%9%8%8%7%7%NorwayPolandUnited KingdomAustriaItalySwedenSloveniaPortugalFranceCzechiaSpainGermanyIrelandSouth KoreaSlovakiaBelgiumTurkeySwitzerlandMexicoFinlandAustraliaJapanCanadaUnited States
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
PMPRB. (May 4, 2020). Uptake of infliximab biosimilars in select countries as of 2018, by share of units [Graph]. In Statista. Retrieved April 26, 2025, from https://www.statista.com/statistics/1119054/uptake-of-infliximab-biosimilars-in-oecd-countries/
PMPRB. "Uptake of infliximab biosimilars in select countries as of 2018, by share of units." Chart. May 4, 2020. Statista. Accessed April 26, 2025. https://www.statista.com/statistics/1119054/uptake-of-infliximab-biosimilars-in-oecd-countries/
PMPRB. (2020). Uptake of infliximab biosimilars in select countries as of 2018, by share of units. Statista. Statista Inc.. Accessed: April 26, 2025. https://www.statista.com/statistics/1119054/uptake-of-infliximab-biosimilars-in-oecd-countries/
PMPRB. "Uptake of Infliximab Biosimilars in Select Countries as of 2018, by Share of Units." Statista, Statista Inc., 4 May 2020, https://www.statista.com/statistics/1119054/uptake-of-infliximab-biosimilars-in-oecd-countries/
PMPRB, Uptake of infliximab biosimilars in select countries as of 2018, by share of units Statista, https://www.statista.com/statistics/1119054/uptake-of-infliximab-biosimilars-in-oecd-countries/ (last visited April 26, 2025)
Uptake of infliximab biosimilars in select countries as of 2018, by share of units [Graph], PMPRB, May 4, 2020. [Online]. Available: https://www.statista.com/statistics/1119054/uptake-of-infliximab-biosimilars-in-oecd-countries/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.